Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can the Dose of Belimumab be Reduced in Patients with Systemic Lupus Erythematosus?
Rua-Figueroa I, Altabás-González I, Mouriño C, Roberts K, Hernández-Martín A, Casafont-Solé I, Font-Urgelles J, Román-Ivorra JA, Navarro MR, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blazquez-Canamero MA, Fernandez-Cid CM, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo J, de Dios JR, Alvarez-Rodríguez B, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Pego-Reigosa JM. Rua-Figueroa I, et al. Among authors: frade sosa b. Rheumatology (Oxford). 2024 May 13:keae270. doi: 10.1093/rheumatology/keae270. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38741198
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I, Pego-Reigosa JM, Mouriño C, Jiménez N, Hernández-Martín A, Casafont-Solé I, Urguelles JF, Román-Ivorra JA, Navarro MR, Galindo-Izquierdo M, Salman-Monte TC, Narváez J, Vidal-Montal P, García-Villanueva MJ, Garrote-Corral S, Blázquez-Cañamero MÁ, Marras C, Piqueras-García M, Martínez-Barrio J, Sánchez-Lucas M, Cortés-Hernández J, Penzo E, Calvo J, de Dios JR, Rodríguez BÁ, Vasques-Rocha M, Tomero E, Menor-Almagro R, Gandía M, Gómez-Puerta JA, Frade-Sosa B, Ramos-Giráldez C, Trapero-Pérez C, Diez E, Moriano C, Muñoz-Jiménez A, Rúa-Figueroa I. Altabás-González I, et al. Among authors: frade sosa b. Rheumatology (Oxford). 2024 Mar 15:kead696. doi: 10.1093/rheumatology/kead696. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38490245
Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study.
Frade-Sosa B, Ponce A, Ruiz-Ortiz E, De Moner N, Gómara MJ, Azuaga AB, Sarmiento-Monroy JC, Morlà R, Ruiz-Esquide V, Macías L, Sapena N, Tobalina L, Ramirez J, Cañete JD, Yague J, Auge JM, Gomez-Puerta JA, Viñas O, Haro I, Sanmarti R. Frade-Sosa B, et al. Rheumatol Ther. 2024 Jun;11(3):501-521. doi: 10.1007/s40744-024-00650-9. Epub 2024 Mar 2. Rheumatol Ther. 2024. PMID: 38430455 Free PMC article.
Synovial tissue features associated with poor prognosis in inflammatory arthritis.
Azuaga AB, Cuervo A, Celis R, Frade-Sosa B, Sarmiento-Monroy JC, Ruiz-Esquide V, Gómez-Puerta JA, Sanmartí R, Ramírez J. Azuaga AB, et al. Among authors: frade sosa b. Arthritis Res Ther. 2024 Jan 10;26(1):18. doi: 10.1186/s13075-023-03255-9. Arthritis Res Ther. 2024. PMID: 38200561 Free PMC article.
Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus.
Urrego-Callejas T, Hernández A, Ruiz Giraldo S, Frade-Sosa B, Vanegas-García AL, Muñoz CH, Rua C, Duque Botero J, González LA, Vásquez G, Gómez-Puerta JA. Urrego-Callejas T, et al. Among authors: frade sosa b. Reumatol Clin (Engl Ed). 2023 Apr;19(4):197-203. doi: 10.1016/j.reumae.2023.01.001. Reumatol Clin (Engl Ed). 2023. PMID: 37061281 Free article.
22 results